Nguyen MK, Ornekian V, Kao L, Butch AW, Kurtz I. Defining the role of albumin infusion in cirrhosis-associated hyponatremia. Am J Physiol Gastrointest Liver Physiol 307: G229 -G232, 2014. First published May 15, 2014; doi:10.1152/ajpgi.00424.2013.-The presence of negatively charged, impermeant proteins in the plasma space alters the distribution of diffusible ions in the plasma and interstitial fluid (ISF) compartments to preserve electroneutrality and is known as GibbsDonnan equilibrium. In patients with hypoalbuminemia due to underlying cirrhosis, the decrease in the plasma water albumin concentration ([Alb Ϫ ]pw) would be expected to result in a decrease in the plasma water sodium concentration ([Na ϩ ]pw) due to an alteration in the distribution of Na ϩ between the plasma and ISF. In addition, cirrhosis-associated hyponatremia may be due to the renal diluting defect resulting from the intravascular volume depletion due to gastrointestinal losses and overdiuresis and/or decreased effective circulatory volume secondary to splanchnic vasodilatation. Therefore, albumin infusion may result in correction of the hyponatremia in cirrhotic patients either by modulating the Gibbs-Donnan effect due to hypoalbuminemia or by restoring intravascular volume in patients with intravascular volume depletion due to gastrointestinal losses and overdiuresis. However, the differential role of albumin infusion in modulating the [Na ϩ ]pw in these patients has not previously been analyzed quantitatively. In the present study, we developed an in vitro assay system to examine for the first time the quantitative effect of changes in albumin concentration on the distribution of Na ]pw as predicted by Gibbs-Donnan equilibrium. However, based on our findings, we predict that the improvement in cirrhosis-associated hyponatremia due to intravascular volume depletion results predominantly from the restoration of intravascular volume rather than alterations in Gibbs-Donnan equilibrium.
ϩ ]pw) due to an alteration in the distribution of Na ϩ between the plasma and ISF. In addition, cirrhosis-associated hyponatremia may be due to the renal diluting defect resulting from the intravascular volume depletion due to gastrointestinal losses and overdiuresis and/or decreased effective circulatory volume secondary to splanchnic vasodilatation. Therefore, albumin infusion may result in correction of the hyponatremia in cirrhotic patients either by modulating the Gibbs-Donnan effect due to hypoalbuminemia or by restoring intravascular volume in patients with intravascular volume depletion due to gastrointestinal losses and overdiuresis. However, the differential role of albumin infusion in modulating the [Na ϩ ]pw in these patients has not previously been analyzed quantitatively. In the present study, we developed an in vitro assay system to examine for the first time the quantitative effect of changes in albumin concentration on the distribution of Na ϩ between two compartments separated by a membrane that allows the free diffusion of Na ]pw as predicted by Gibbs-Donnan equilibrium. However, based on our findings, we predict that the improvement in cirrhosis-associated hyponatremia due to intravascular volume depletion results predominantly from the restoration of intravascular volume rather than alterations in Gibbs-Donnan equilibrium.
dysnatremias; hypoalbuminemia; Gibbs-Donnan equilibrium HYPONATREMIA IS A COMMON ELECTROLYTE disorder in patients with cirrhosis. The hyponatremia in patients with cirrhosis is attributed to the renal diluting defect due to either intravascular volume depletion or diminished effective circulatory volume resulting from splanchnic vasodilatation (2, 4, 5, 11) . The intravascular volume depletion is due to the lactulose-induced osmotic diarrhea and overly aggressive diuresis in these patients. It is also well known that the presence of negatively charged, impermeant albumin in the plasma space alters the distribution of diffusible Na ϩ in the plasma and interstitial fluid (ISF) compartments to preserve electroneutrality (8) . Therefore, hypoalbuminemia would be expected to result directly in a decrease in the plasma water sodium concentration ( ]) that would allow clinicians to estimate the magnitude of the contribution of the GibbsDonnan effect to the hyponatremia in patients with cirrhosis. The purpose of this study was to differentiate quantitatively the contribution of Gibbs-Donnan effect from the renal diluting defect due to either intravascular volume depletion or diminished effective circulatory volume in the generation of hyponatremia in cirrhotic patients.
MATERIALS AND METHODS
Salt-free albumin was generated using a mixed cation and anion exchange resin (MBD-10-LTOC; ResinTech, West Berlin, NJ) that exchanges Na ϩ for H ϩ and Cl Ϫ for OH Ϫ . Human albumin (126654; Calbiochem, EMD Biosciences, Darmstadt, Germany) was dissolved in ultrapure water (1 g/5 ml) and was subsequently loaded on a column containing an equal volume of the exchange resin equilibrated with ultrapure water at a flow rate of 10 ml/h. The effluent solution was reloaded and run on the column five separate times. The salt-free albumin solution was lyophilized using a Savant Speed Vac concentrator (Savant Instruments, Halbrook, NY).
We examined the role of varying albumin concentrations on the distribution of Na ϩ between two compartments in vitro separated by a semipermeable dialysis membrane (Spectra/Por Dispodialyzer, 15,000 mol wt cutoff; Spectrum Laboratories) (Fig. 1) . To simulate the in vivo distribution of H 2O between the plasma and ISF, 2 ml of a standard 127 mM NaCl solution were added to one compartment, and 9.3 ml were added to the other compartment since the plasma volume is known to be approximately one-fifth of the extracellular volume (plasma 3 l, ISF 14 l) (9) . A standard 127 mM NaCl solution was chosen to obtain [Na ϩ ] in the protein-containing compartment in the 129 -140 range. Salt-free albumin was dissolved in the 2 ml NaCl solution in various amounts to vary the albumin concentration. Electrochemical equilibrium between the two compartments was then allowed to occur for 24 h.
Once electrochemical equilibrium was complete, duplicate measurements of the [Na ] is also measured on each sample using an Olympus AU5400 automated chemistry analyzer.
Statistics. 
RESULTS
It is well known that Gibbs-Donnan equilibrium is established when the altered distribution of Na ϩ results in electrochemical equilibrium (10) . At Gibbs-Donnan equilibrium, the chemical gradient is equal in magnitude and opposite in direction to the electrical gradient as depicted by the following equation (10):
where F is Faraday's constant; R is ideal gas constant; T is absolute temperature; [Na ϩ ] 1 is the sodium concentration in the protein-containing compartment; and [Na ϩ ] 2 is the sodium concentration in the non-protein-containing compartment.
As expected, the [Na ϩ ] was greater in the albumin-containing compartment due to Gibbs-Donnan equilibrium ( 
Based on Eq. 1, the E m imposed by negatively charged albumin can be calculated based on the ratio of sodium concentration in the protein-containing compartment and sodium concentration in the non-protein-containing compartment, (Table 2) :
The relationship between [Alb 
DISCUSSION
Hyponatremia commonly occurs in patients with advanced cirrhosis. In cirrhosis, the pathogenesis is thought to be related to the hemodynamic changes and secondary neurohumoral adaptations that occur in these patients (2, 4, 5, 11). Patients with cirrhosis usually have a marked reduction in systemic vascular resistance and mean arterial pressure due to splanchnic vasodilatation. The reduction in pressure at the carotid and renal baroreceptors induced by splanchnic vasodilatation leads to activation of the sodium-retaining neurohumoral mechanisms in an attempt to restore perfusion pressure to normal. These include the renin-angiotensin system, the sympathetic nervous system, and antidiuretic hormone (ADH). Of these three neurohumoral mechanisms, increased ADH secretion plays a central role in the pathogenesis of hyponatremia in patients with cirrhosis since suppression of ADH release is required to excrete the daily water intake. In addition, in patients with significant lactulose-induced osmotic diarrhea and overly aggressive diuresis of the ascites and peripheral edema, intravascular volume depletion can result in disruption in the mechanisms underlying urinary free water excretion. The normal physiology of urinary dilution is determined by numerous factors such as normal glomerular filtration rate, adequate delivery of fluid to the diluting segments of the nephron mediated by inhibition of proximal Na ϩ and H 2 O absorption, intact Na ϩ and Cl Ϫ reabsorption at both the thick ascending limb of the loop of Henle and distal convoluted tubules, and the inhibition of H 2 O absorption in the collecting duct resulting from the suppression of ADH secretion. The renal diluting defect associated with intravascular volume depletion results from the decreased glomerular filtration rate, avid proximal sodium and fluid reabsorption with resultant diminished delivery of fluid to the diluting segments of the nephron, inhibition of tubular Na ϩ and Cl Ϫ reabsorption by diuretics, and hypovolemia-induced increased secretion of ADH. In these cirrhotic patients with intravascular volume depletion, albumin infusion may ameliorate the hyponatremia by expanding the intravascular volume (1, 3, 6, 7) . Indeed, two studies have suggested that the administration of albumin, which aids the expansion of plasma volume, may improve plasma sodium concentration in patients with cirrhosis (6, 7).
It is also well known that the [Na ϩ ] pw and ISF [Na ϩ ] differ despite the high permeability of Na ϩ across the capillary membrane that separates these two fluid compartments (8, 9) . This difference in ionic concentrations between the plasma and the ISF is due to the much higher concentration of proteins in the plasma compared with the ISF. Proteins are large-molecular-weight substances and therefore do not pass the capillary membrane easily. This lack of protein permeability across capillary membranes is responsible for causing ionic concentration differences between the plasma and ISF (8, 9) . Because proteins are negatively charged nonpermeant molecules present predominantly in the plasma space, their presence will attract positively charged Na ϩ . The distribution of Na ϩ is altered to preserve electroneutrality in the plasma and ISF. As a result, the [Na ] pw ), can directly lead to amelioration of the hyponatremia due to the direct effect of Gibbs-Donnan equilibrium that is independent of its effect on plasma volume expansion. To test this hypothesis, we examined the role of varying albumin concentrations on the distribution of Na ϩ between two compartments in vitro. Because hyponatremia in cirrhosis may be caused by the defect in urinary free water excretion resulting from intravascular volume depletion and/or decreased effective circulatory volume, the role of the renal diluting defect must be distinguished clinically from the direct effect of changes in the [Alb Ϫ ] pw on alterations in the [Na ϩ ] pw due to Gibbs-Donnan equilibrium. Therefore, by evaluating the role of varying albumin concentrations on the distribution of Na ϩ between two compartments in vitro, one can directly for the first time determine quantitatively the contribution of Gibbs-Donnan equilibrium to the development of cirrhosis-associated hyponatremia. As expected, the [Na ϩ ] is greater in the albumin-containing compartment due to Gibbs-Donnan equilibrium as shown in Table 1 ] (r ϭ 0.9). According to this equation, the ratio of the sodium concentration in the protein-containing compartment and sodium concentration in the non-protein-containing compartment is 1.04 at an albumin concentration of 4 g/dl. This finding is consistent with the in vivo Gibbs-Donnan ratio for the distribution of univalent cations between the plasma and ISF given that the Gibbs-Donnan ratio for the distribution of Na ϩ between the plasma and ISF is 1.05 (8) .
In terms of clinical implications, based on Eq. 2, as the plasma [Alb Ϫ ] increases from 2 to 4 g/dl, the plasma [Na ϩ ] is expected to increase by 2 mmol/l. Therefore, within the physiological range of alterations in the plasma [Alb Ϫ ], improvement in cirrhosis-associated hyponatremia resulting from albumin infusion is due predominantly to plasma volume expansion rather than alterations in Gibbs-Donnan equilibrium. In other words, in patients with cirrhosis-associated hyponatremia and hypoalbuminemia, albumin infusion would be expected to significantly improve the hyponatremia in patients with clinical evidence of true intravascular volume depletion (i.e., low central venous pressure). In contrast, albumin infusion would not be expected to significantly improve the hyponatremia in patients with cirrhosis-associated hyponatremia and hypoalbuminemia who have clinical evidence consistent with intravascular hypervolemia (i.e., elevated central venous pressure).
Limitations. A limitation of our in vitro study is that the in vitro semipermeable membrane used in our experiment does not have active transporters like the cell membrane. Indeed, the Na ϩ -K ϩ -ATPase in the cell membrane actively pumps Na ϩ out of the cell. However, the subsequent distribution of Na ϩ between the plasma and ISF will be determined by the GibbsDonnan effect due to impermeant plasma proteins. Consistent with this fact, the in vitro Gibbs-Donnan ratio of the sodium concentration in the protein-containing compartment and sodium concentration in the non-protein-containing compartment of 1.04 at an albumin concentration of 4 g/dl is similar to the in vivo Gibbs-Donnan ratio for the distribution of Na ϩ between the plasma and ISF of 1.05.
It is well known that the diffusion of middle-to large-molecular-weight solutes across semipermeable membranes is dependent on the effective pore size of the membrane. The effective pore size of the in vitro dialysis membrane (15,000 mol wt cutoff) used in this study may differ from that of the cell membrane in vivo. However, this is not a concern since, in our study, the diffusion of small ions such as Na ϩ (atomic weight 23) was unlikely affected by the pore size of the semipermeable membrane used.
In conclusion, we have demonstrated for the first time that changes in the [Alb ], correction of cirrhosis-associated hyponatremia due to intravascular volume depletion by albumin infusion results predominantly from plasma volume expansion rather than alterations in Gibbs-Donnan equilibrium.
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